U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369284) titled 'Melatonin for Glycemic Control in Gestational Diabetes Mellitus' on Jan. 05.
Brief Summary: The goal of this randomized, double-blind, placebo-controlled clinical trial is to evaluate whether melatonin supplementation improves glycemic control in pregnant women diagnosed with gestational diabetes mellitus (GDM).
The main question it aims to answer is:
Does melatonin supplementation help with glycemic control, especially in lowering fasting plasma glucose level?
Researchers will compare melatonin to a placebo (a look-alike substance that contains no melatonin) to see if melatonin works to improve glycemic control.
Participants wi...